Cumulatively, our findings that APLP2 functions contribute to migration and metastasis, together with our previous discovery of the ability of beta-secretase inhibition to lessen pancreatic cancer cell growth [5], suggest that APLP2 could be a viable target for attacking pancreatic cancer. This evidence concerns the gene APLP2 and pancreatic neoplasm.